Oxidative stress-dependent MMP-13 activity underlies glucose neurotoxicity
Ashley L Waldron1, Patricia A Schroder1, Kelly L Bourgon1
1Davis Center for Regenerative Biology and Medicine, MDI Biological Laboratory, Kathryn W. Davis Building 227, Old Bar Harbor Road, Salisbury Cove, ME 04672, USA.
Background:
A complication of diabetes is neuropathy, a condition of sensory axon degeneration that originates in the epidermis. The mechanisms remain unknown but reactive oxygen species (ROS) have been implicated in this condition. In this study, we assessed the role of ROS and a candidate downstream target, MMP-13 in glucose-induced sensory axon degeneration in zebrafish and mice.
Methods:
The effects of glucose on metabolism and sensory axon degeneration were assessed using qPCR and live imaging. ROS were analyzed using pentafluorobenzene-sulfonyl fluorescein and activation of the NF-κB stress response was determined using Tg(NF-κB:GFP) zebrafish. The role of MMP-13 and ROS in glucose-dependent axon degeneration was determined in zebrafish following treatment with the antioxidant, N-acetylcysteine and the MMP-13 inhibitor, DB04760. Neuropathic mice fed on a high-fat/high-sugar diet were treated with the MMP-13 inhibitor, CL-82198 to assess sensory recovery.
Results:
Glucose treatment of zebrafish induced metabolic changes that resemble diabetes. Sensory axon degeneration was mediated by ROS-induced MMP-13 and prevented upon antioxidant treatment or MMP-13 inhibition. MMP-13 inhibition also reversed neuropathy in diabetic mice.
Conclusion:
We demonstrate that zebrafish are suitable to study glucose-induced neurotoxicity. Given the effects in zebrafish and mice, MMP-13 inhibition may be beneficial in the treatment of human diabetic neuropathy.
Insights
Diabetic neuropathy involves sensory axon degeneration. This study shows reactive oxygen species (ROS) and MMP-13 drive this degeneration, and inhibiting MMP-13 may treat diabetic neuropathy.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Cell Biology
Background:
- Diabetic neuropathy is a complication characterized by sensory axon degeneration.
- The underlying mechanisms are unclear, but reactive oxygen species (ROS) are implicated.
- This study investigates the roles of ROS and MMP-13 in glucose-induced axon degeneration.
Purpose of the Study:
- To assess the role of ROS and MMP-13 in glucose-induced sensory axon degeneration.
- To evaluate the potential of MMP-13 inhibition as a therapeutic strategy for diabetic neuropathy.
Main Methods:
- Utilized zebrafish and mice models to study glucose-induced metabolic changes and axon degeneration.
- Employed qPCR, live imaging, and specific fluorescent probes to analyze ROS and NF-κB activation.
- Tested the efficacy of antioxidant treatment and MMP-13 inhibitors (DB04760, CL-82198) in preventing or reversing neuropathy.
Main Results:
- Glucose treatment in zebrafish mimicked diabetic metabolic changes and induced sensory axon degeneration.
- Degeneration was mediated by ROS-induced MMP-13, and was prevented by antioxidant or MMP-13 inhibition.
- MMP-13 inhibition reversed neuropathy in both zebrafish and diabetic mice models.
Conclusions:
- Zebrafish serve as a viable model for studying glucose-induced neurotoxicity.
- MMP-13 inhibition shows promise as a therapeutic approach for human diabetic neuropathy, based on findings in zebrafish and mice.
More Related Videos
06:46Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
12:24Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
Published on: September 28, 2016
Related Concept Videos
Oxidation Numbers
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Carbon-13 (¹³C) NMR: Overview
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Oxidation-Reduction Reactions
